Allergic Rhinitis and Asthma: Genetic Linkage Regions

allergic rhinitis asthma
Allergic rhinitis and asthma are common comorbidities. Like asthma, the presence of a genetic component in allergic rhinitis has been well established. To identify genetic linkage regions unique to allergic rhinitis, as well as those shared by allergic rhinitis and asthma, a genome screen study was conducted. A total of 295 families in the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) containing 1317 subjects were genotyped for 396 microsatellite markers. The families included had two siblings with DNA available and at least one asthmatic subject. Three definitions of allergic rhinitis were used, two binary and one categorical. To investigate linkages specific to allergic rhinitis (without asthma), linkage analyses were also conducted in 185 families with at most one asthmatic sib. (more…)

Anti IgE Therapy Tolerability with Omalizumab Therapy in Allergic Asthma Patients

Anti IgE Therapy
Anti-IgE therapy could be particularly beneficial for patients with concomitant asthma and rhinitis as it targets a common factor in the two diseases. Omalizumab is significantly more efficacious than placebo in preventing asthma exacerbations and in improving disease-related quality of life scores when added to standard asthma and rhinitis therapies. (more…)

Allergy Immunotherapy with Depigmented Glutaraldehyde-Polymerized Extracts

Allergy Immunotherapy
Allergic rhinitis is a very common problem associated with poor quality of life, reductions in social and work activities and poor interpersonal relationships. The main goal of the management of allergic rhinitis is to improve the quality of life. Immunotherapy is a specific therapy for allergic rhinitis and several reports have documented the safety and efficacy of this treatment . Safety has been a key issue in immunotherapy and various modalities are being investigated to make allergy immunotherapy more tolerable and safe to administer. (more…)

Allergic March of Childhood and Allergen Sensitization

Natural history studies with the following design features provide a firm epidemiologic foundation for risk factor assessments and etiologic hypotheses:
(1) long-term cohort studies of a prospective design minimize biases resulting from poor parental recall;
(2) multiple evaluations over time provide important checkpoints during the dynamic period of childhood growth and development; and
(3) the inclusion of objective disease measurements strengthens these studies by validating subjective disease assessments (i.e. questionnaire data). (more…)

The Natural Course Of Atopic Dermatitis In Association With Asthma

Atopic Dermatitis Asthma
Atopic Dermatitis is considered to be one of the first manifestations in the atopic march. The aim of this study was to investigate prospectively the natural course of Atopic Dermatitis to determine factors influencing its prognosis and to analyse the relationship of Atopic Dermatitis with childhood asthma. The Multicenter Allergy Study, a German birth cohort, followed 1314 children from birth to age 7 years. Physical examinations, parental interviews on atopic symptoms and diagnoses, and determination of specific immunoglobulin (Ig)E levels were performed regularly. (more…)

Atopic Disorders: Diverging Prevalence Trends in Children

Atopic Disorders
During recent decades there has been extensive epidemiological research to explore the increasing prevalence of asthma and allergy in childhood. The worldwide variations in the prevalence of these diseases necessitate regional rapport. Furthermore, time-trend analyses with comparable methods are important in order to monitor the rapidly changing prevalence of these atopic diseases. Three cross sectional questionnaire-based studies of asthma and allergy in school children were conducted in the counties of Troms and Finnmark in northern Norway in 1985, 1995 and 2000. (more…)

Exhaled Leukotrienes In Asthma & Non-Asthmatic Adult Patients With Seasonal Allergic Rhinitis

Exhaled Leukotrienes
Leukotrienes are present in increased amounts in exhaled breath condensate (EBC) in patients with asthma. So far, no data have been reported about leukotriene levels in non-asthmatic patients with Seasonal Allergic Rhinitis. The aim of the study was to find out whether the leukotriene levels in exhaled breath condensate were increased in the non-asthmatic adult patients with Seasonal Allergic Rhinitis both during and after the pollen season in comparison with healthy controls, and to assess changes in leukotriene levels after the pollen season. Twentynine non-asthmatic adult patients with Seasonal Allergic Rhinitis and 50 healthy non-smoking controls underwent measurement of exhaled leukotrienes in the exhaled breath condensate during and after the pollen season. Spirometry, skin-prick tests and total IgE were also evaluated. (more…)

Atopic Dermatitis Adult Patients: A Questionnaire Study

Atopic Dermatitis Adult
Atopic Dermatitis is a chronic relapsing skin disease. Several investigations concerning the long-term prognosis of Atopic Dermatitis in children and teenagers have been performed but there are few data for adults. The aim of this study was to investigate the prognosis and prognostic factors in adult patients with Atopic Dermatitis using a long-term follow-up (25–38 years). A follow-up questionnaire was sent to 922 Atopic Dermatitis patients examined in an out-patient clinic between 1960 and 1973 among 1366 registered patients with Atopic Dermatitis. The patients were aged 20 years or older when they visited the clinic and 45 years or older when they answered the follow-up questionnaire. (more…)